Markel Group Inc. filings document the financial reporting, governance, and capital-structure disclosures of a diversified holding company centered on specialty insurance. Its regulatory record includes 8-K reports for annual and quarterly results, Regulation FD materials such as shareholder letters, leadership and compensation changes, and reporting changes tied to business re-segmentation.
Proxy filings describe board matters, executive compensation, shareholder voting items, and equity-award disclosures. Other filings address registered securities and plan-interest matters, including Costa Farms LLC 401(k) Plan disclosures, while preserving Markel Group’s continuing reporting obligations for its common shares.
MARKEL GROUP INC. director Mark Besca reported receiving a grant of 89 shares of common stock as equity compensation. The shares were awarded at a price of $0.00 per share and increased his directly held position to 1,141.2525 shares after the transaction.
The award is structured as restricted stock granted under the MKL 2024 Equity Incentive Compensation Plan and will vest, subject to certain conditions, on May 20, 2027. This is a routine compensation-related acquisition rather than an open-market purchase.
Harris Greta J reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Greta J. Harris received a grant of 89 shares of common stock as equity compensation at no cash cost to her. These restricted shares were issued under the MKL 2024 Equity Incentive Compensation Plan and will vest, subject to certain conditions, on May 20, 2027. Following this grant, she directly holds 721 shares of Markel Group common stock.
Cunningham Lawrence A reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Lawrence A. Cunningham received an award of 89 shares of common stock on May 20, 2026. This was a restricted stock grant under the MKL 2024 Equity Incentive Compensation Plan at no cash cost to him.
The restricted shares will vest, subject to certain conditions, on May 20, 2027. After this grant, Cunningham directly holds a total of 1,008.8381 shares of Markel common stock, reflecting a routine equity-based compensation award rather than an open-market purchase.
OREILLY MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Michael O’Reilly received a grant of 89 shares of common stock as equity compensation. The award was made at no cash cost to him and increased his direct holdings to about 3,844.7641 shares.
The footnote explains this is restricted stock granted under the MKL 2024 Equity Incentive Compensation Plan. These shares are scheduled to vest on May 20, 2027, provided specified conditions are met, which makes this a standard, long-term incentive grant rather than an open-market purchase or sale.
Housel Morgan E. reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Morgan E. Housel received a grant of 89 shares of restricted common stock at no cost as equity compensation. After this award, he directly holds 963.05 shares. The restricted stock was granted under the MKL 2024 Equity Incentive Compensation Plan and will vest on May 20, 2027, subject to certain conditions.
Puckett A. Lynne reported acquisition or exercise transactions in this Form 4 filing.
Markel Group Inc. director Lynne Puckett reported an equity compensation grant of 89 shares of common stock, classified as restricted stock awarded at $0.00 per share under the MKL 2024 Equity Incentive Compensation Plan.
These restricted shares are scheduled to vest, subject to certain conditions, on May 20, 2027. Following the grant, she directly holds 441.4802 shares of Markel common stock and indirectly holds 1,463 shares through a trust where she and her spouse are co-trustees and beneficiaries.
Leopold Diane reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Diane Leopold reported a compensation-related stock grant and updated holdings. She received 89 shares of Common Stock as a restricted stock award at $0.00 per share under the MKL 2024 Equity Incentive Compensation Plan, bringing her direct holdings to 2,279.0993 shares. The restricted shares will vest, subject to certain conditions, on May 20, 2027. The filing also reflects 550 shares of Common Stock held indirectly through her spouse, for which beneficial ownership is expressly disclaimed.
Markel Group Inc. shareholders approved an amendment to the company’s Amended and Restated Articles of Incorporation that reduces the default voting requirement under Virginia law to a majority of all votes entitled to be cast for major corporate actions such as mergers, dissolutions, and significant asset sales. At the same annual meeting, shareholders elected all director nominees, approved on an advisory basis the compensation of named executive officers, and ratified KPMG LLP as independent auditor for the year ending December 31, 2026. Shareholders rejected two proposals: one seeking a report on strategies to mitigate material environmental risks and another seeking the ability for shareholders to call a special shareholder meeting.
Markel Group Inc. is sharing a leadership presentation at its 2026 Annual Meeting of Shareholders, outlining long-term financial performance and strategy. The slides show operating revenues rising across five-year buckets to $68.7 billion for 2021–2025 and consolidated adjusted operating income reaching $9.2 billion over the same period.
Adjusted operating income grew to $2.323 billion for the last twelve months ended Q1 2026, with a five-year compound annual growth rate of 16% for the Industrial, Financial, and Consumer & Other segments. These segments together also delivered five-year average organic revenue growth of 7.5% and a five-year average pre-tax return on tangible capital of 26%, including 27% in 2025.
The company highlights a declining share count from 13.8 million in 2020 to 12.6 million in 2025, underwriting combined ratios generally in the mid-90% range, and capital allocation that returned $2.1 billion from operating companies while investing $1.3 billion into acquisitions. Management emphasizes specialty insurance focus, decentralized P&L ownership, and “The Markel Style” culture as competitive advantages, and uses non-GAAP measures such as adjusted operating income and organic revenue growth with reconciliations provided in appendices.